Back
EHRA Premium Access

The subcutaneous defibrillator in patients with low BMI - insights from a large European multicenter registry

Session: ePosters Day 2
Topic: Implantable Cardioverter-Defibrillator (ICD)
Speaker: Mrs J. Vogler (Luebeck, DE)
Event: EHRA 2022

Congress Presentation

0

About the speaker

Mrs Julia Vogler

University of Luebeck, Luebeck (Germany)
0 follower

131 more presentations in this session

Folates dysmetabolism promotes atrial cardiomyopathy/fibrillation through a cardiac-bone marrow networking involving endothelial progenitor cell dysfunction and erythropoiesis diversion

Speaker: Doctor L. Sgarra (Acquaviva Delle Fonti, IT)

Access
Abstract
Slides
0
Thumbnail

Pure and impure tachycardiomiopathy: key differences and long term prognosis

Speaker: Doctor G. Stronati (Ancona, IT)

Access
Abstract
Slides
0
Thumbnail

Prognostic value of plasma neutrophil gelatinase-associated lipocalin for cardiovascular events in patients with chronic heart failure and atrial fibrillation

Speaker: Professor D. Lashkul (Zaporizhzhia, UA)

Access
Abstract
Slides
0
Thumbnail

Interatrial block as a prognosticator of new-onset atrial fibrillation: prospective observational study of 8012 adults

Speaker: Mr E. Abdovic (Zenica, BA)

Access
Abstract
Slides
1
Thumbnail

CHA2DS2-VASc score and the risk of death in atrial fibrillation

Speaker: Doctor A. Aro (Helsinki, FI)

Access
Abstract
Slides
0
Thumbnail

Access the full session

ePosters Day 2

Speakers: Mrs J. Vogler, Doctor L. Sgarra, Doctor G. Stronati, Professor D. Lashkul, Mr E. Abdovic...
Access
0
Thumbnail

About the event

Image

EHRA 2022

3 April - 5 April 2022

Sessions Presentations

Congress
logo Image

Related content

EHRA Premium Access

Comparative of stylet-driven versus lumenless technique for left bundle branch pacing: implant results and follow-up outcomes

5 April 2022

EHRA Premium Access

Conduction system pacing in paediatric patients: a single centre experience

3 April 2022

EHRA Premium Access

Pulsed field ablation of atrial fibrillation: recurrence rate after first pulmonary vein isolation and first insights into durability at redo procedures

3 April 2022

ESC 365 is supported by

logo Novo Nordisk